Menopausal symptoms

BMJ

Volumn 321, Issue 7275, 2000, Pages 1516-

  Rymer, Janice ^a   Morris, Edward P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007679607     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.321.7275.1516     Document Type: Article

References (44)

1. Porter M, Penney G, Russell D, Russell E, Templeton A. A population based survey of women's experience of the menopause. Br J Obstet Gynaecol 1996; 103: 1025-1028.
2. Hagsta TA, Janson PO. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand 1986; 134(suppl): 59.
3. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen/progestin interventions trial. Obstet Gynecol 1998; 92: 982-988.
4. Mattsson L-A. Clinical experience with continuous combined transdermal hormone replacement therapy. J Menopause 1999; 6: 25-29.
5. Utian WH, Burry KA, Archer DF, et al. Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group. Am J Obstet Gynecol 1999; 181: 71-79.
6. Cardozo L, Bachmann G, McClish D, Fonda D. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 1998; 2: 722-727.
7. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180: 1072-1079.
8. Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10: 171-176.
9. Zweifel JE, O'Brien WH. A meta-analysis of the effect of HRT upon depressed mood. Psychoneuroendocrinology 1997; 22: 189-212.
10. Haskell SG, Richardson ED, Horwitz RI. The effect of ORT on cognitive function in women: a critical review of the literature. J Clin Epidemiol 1997; 50: 1249-1264.
11. Polo-Kantola P, Erkkola R, Irjala K, Pullinen S, Virtanen I, Polo O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 1999; 71: 873-880.
12. Wiklund I, Karlberg J, Mattsson L. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168: 824-830.
13. Karlberg J, Mattsson L, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995; 74: 367-372.
14. Derman RJ, Dawood MY, Stone S. Quality of life during sequential hormone replacement therapy–a placebo-controlled study. Int J Fertil Menopausal Stud 1995; 40: 73-78.
15. Hilditch JR, Lewis J, Ross AH, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Maturitas 1996; 24: 177-184.
16. Grady D, Sawaya G. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. Am J Med 1998; 105: 41-43.
17. Barrett-Connor E. Fortnightly review: hormone replacement therapy. BMJ 1998; 317: 457-461.
18. Sudlow C, Baigent C, Lonn E, Probstfield J, Ness A, Rihal C. Secondary prevention of ischaemic cardiac events. In: Clinical evidence. BMJ Publishing Group, 2000: 77-106. (No 3; March.)
19. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047-1059.
20. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994; 331: 347-352.
21. Lobo RA, McCormick W, Singer F, Roy S. DMPA compared with conjugated oestrogens for the treatment of postmenopausal women. Obstet Gynecol 1984; 63: 1-5.
22. Aslaksen K, Frankendal B. Effect of oral MPA on menopausal symptoms on patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1982; 61: 423-428.
23. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral MPA in the treatment of postmenopausal symptoms. JAMA 1980; 244: 1443-1445.
24. Bullock JL, Massey FM, Gambrell RD. Use of MPA to prevent menopausal symptoms. Obstet Gynecol 1975; 46: 165-168.
25. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225-228.
26. Reginster JY, Zartarian M, Colau JC. Influence of nomogestrel acetate on the improvement of the quality of life induced by estrogen therapy in menopausal women. Contracept Fertil Sex 1996; 24: 847-851.
27. Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestagen hormone replacement therapy in women with hysterectomy. BMJ 1996; 312: 473-478.
28. Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998; 105: 904-911.
29. Al Azzawi F, Wahab M, Habiba M, Akkad A, Mason T. Continuous combined hormone replacement therapy compared with tibolone. Obstet Gynecol 1999; 93: 258-264.
30. Kicovic PM, Cortes-Prieto J, Luisi M, Milojevic S, Franchi F. Placebo-controlled cross-over study of effects of Org OD14 in menopausal women. Reproduccion 1982; 6: 81-91.
31. Nathorst-Boos J, Hammar M. Effect on sexual life–a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas 1997; 26: 15-20.
32. Moore RA. Livial: a review of clinical studies. Br J Obstet Gynaecol 1999; 106(suppl 19): 1-21.
33. Morris EP, Wilson POG, Robinson J, Rymer JM. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynaecol 1999; 106: 954-959.
34. Benedek-Jaszmann LJ. Long-term placebo-controlled efficacy and safety study of Org OD14 in climacteric women. Maturitas 1987; 1: 25-33.
35. Walker ID, Davidson JF, Richards A, Yates R, McEwan HP. The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women. Thromb Haemost 1985; 53: 303-305.
36. Murkies AL, Lombard C, Stauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189-195.
37. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6: 7-13.
38. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85-92.
39. Edington RF, Chagnon JP. Clonidine (Dixarit) for menopausal flushing. Can Med Assoc J 1980; 123: 23-26.
40. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 1987; 156: 561-565.
41. Simon J, Klaiber E, Wiita B, Bowen A, Yang HM. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999; 6: 138-146.
42. Dow MG, Hart DM, Forrest CA. Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol 1983; 90: 361-366.
43. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47: 339-351.
44. Geddes J, Butler R, Warner J. Depressive disorders. In: Clinical evidence. BMJ Publishing Group, 2000: 434-447. (No 3; March.)